Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma
- 29 June 2022
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (9) , e3689-e3698
Abstract
Context: Sampling of blood in the supine position for diagnosis of pheochromocytoma and paraganglioma (PPGL) results in lower rates of false positives for plasma normetanephrine than seated sampling. It is unclear how inpatient vs outpatient testing and other preanalytical factors impact false positives.Objective: We aimed to identify preanalytical precautions to minimize false-positive results for plasma metanephrines.Methods: Impacts of different blood sampling conditions on plasma metanephrines were evaluated, including outpatient vs inpatient testing, sampling of blood in semi- vs fully recumbent positions, use of cannulae vs direct venipuncture, and differences in outside temperature. A total of 3147 patients at 10 tertiary referral centers were tested for PPGL, including 278 with and 2869 without tumors. Rates of false-positive results were analyzed.Results: Outpatient rather than inpatient sampling resulted in 44% higher plasma concentrations and a 3.4-fold increase in false-positive results for normetanephrine. Low temperature, a semi-recumbent position, and direct venipuncture also resulted in significantly higher plasma concentrations and rates of false-positive results for plasma normetanephrine than alternative sampling conditions, although with less impact than outpatient sampling. Higher concentrations and rates of false-positive results for plasma normetanephrine with low compared with warm temperatures were only apparent for outpatient sampling. Preanalytical factors were without impact on plasma metanephrines in patients with PPGL.Conclusion: Although inpatient blood sampling is largely impractical for screening patients with suspected PPGL, other preanalytical precautions (eg, cannulae, warm testing conditions) may be useful. Inpatient sampling may be reserved for follow-up of patients with difficult to distinguish true- from false-positive results.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (314061271-TRR/CRC 205)
- European Union’s Horizon 2020 Research and Innovation Programme (633983)
This publication has 33 references indexed in Scilit:
- Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2014
- Seasonal variations of plasma normetanephrine levels in Los AngelesEuropean Journal of Endocrinology, 2014
- Seasonal variation in plasma free normetanephrine concentrations: implications for biochemical diagnosis of pheochromocytomaEuropean Journal of Endocrinology, 2014
- Biochemical diagnosis of phaeochromocytoma using plasma‐free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditionsClinical Endocrinology, 2013
- Age at Diagnosis of Pheochromocytoma Differs According to Catecholamine Phenotype and Tumor LocationThe Journal of Clinical Endocrinology & Metabolism, 2011
- Influence of various confounding variables and storage conditions on metanephrine and normetanephrine levels in plasmaClinical Endocrinology, 2010
- False Positive test Results for Pheochromocytoma from 2000 to 2008Experimental and Clinical Endocrinology & Diabetes, 2009
- The Protean Manifestations of PheochromocytomaHormone and Metabolic Research, 2009
- Biochemical and Clinical Manifestations of Dopamine-Producing Paragangliomas: Utility of Plasma MethoxytyramineThe Journal of Clinical Endocrinology & Metabolism, 2005
- Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test ResultsThe Journal of Clinical Endocrinology & Metabolism, 2003